IL122247A0 - Use of sulfamic acid derivatives acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels - Google Patents
Use of sulfamic acid derivatives acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levelsInfo
- Publication number
- IL122247A0 IL122247A0 IL12224796A IL12224796A IL122247A0 IL 122247 A0 IL122247 A0 IL 122247A0 IL 12224796 A IL12224796 A IL 12224796A IL 12224796 A IL12224796 A IL 12224796A IL 122247 A0 IL122247 A0 IL 122247A0
- Authority
- IL
- Israel
- Prior art keywords
- pct
- medicament
- manufacture
- acid derivatives
- sulfamic acid
- Prior art date
Links
- -1 sulfamic acid derivatives acyl sulfonamides Chemical class 0.000 title 2
- 102000004895 Lipoproteins Human genes 0.000 title 1
- 108090001030 Lipoproteins Proteins 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 229940124530 sulfonamide Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000001624 naphthyl group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 208000018262 Peripheral vascular disease Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 208000026106 cerebrovascular disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 208000037803 restenosis Diseases 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US303195P | 1995-08-04 | 1995-08-04 | |
| PCT/US1996/011366 WO1997005868A1 (en) | 1995-08-04 | 1996-07-08 | Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL122247A0 true IL122247A0 (en) | 1998-04-05 |
Family
ID=21703764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12224796A IL122247A0 (en) | 1995-08-04 | 1996-07-08 | Use of sulfamic acid derivatives acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6117909A (pl) |
| EP (1) | EP0841913B1 (pl) |
| JP (1) | JPH11510184A (pl) |
| KR (1) | KR19990036127A (pl) |
| CN (1) | CN1192140A (pl) |
| AT (1) | ATE232097T1 (pl) |
| AU (1) | AU716255B2 (pl) |
| BG (1) | BG63863B1 (pl) |
| CA (1) | CA2221729A1 (pl) |
| CZ (1) | CZ26198A3 (pl) |
| DE (1) | DE69626118T2 (pl) |
| DK (1) | DK0841913T3 (pl) |
| EA (1) | EA002435B1 (pl) |
| EE (1) | EE9800037A (pl) |
| ES (1) | ES2191762T3 (pl) |
| GE (1) | GEP20012511B (pl) |
| HR (1) | HRP960341A2 (pl) |
| HU (1) | HUP9900668A3 (pl) |
| IL (1) | IL122247A0 (pl) |
| NO (1) | NO980466L (pl) |
| NZ (1) | NZ312571A (pl) |
| PL (1) | PL185943B1 (pl) |
| PT (1) | PT841913E (pl) |
| SK (1) | SK12598A3 (pl) |
| UA (1) | UA46030C2 (pl) |
| WO (1) | WO1997005868A1 (pl) |
| ZA (1) | ZA966617B (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1584333A3 (en) * | 1998-01-28 | 2009-04-29 | Warner-Lambert Company LLC | Use of acetylcoenzime A inhibitors for treating Alzheimer's disease |
| CN1310629A (zh) * | 1998-07-21 | 2001-08-29 | 沃尼尔·朗伯公司 | 用于治疗动脉粥样硬化损伤的acat和mmp抑制剂的合并给药 |
| IT1303249B1 (it) * | 1998-10-23 | 2000-11-06 | Dompe Spa | Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono. |
| HUP0203160A3 (en) * | 1999-11-05 | 2006-02-28 | Warner Lambert Co | Prevention of plaque rupture by acat inhibitors |
| CA2369967A1 (en) * | 2001-02-12 | 2002-08-12 | Joseph Anthony Cornicelli | Methods of treating nuclear factor-kappa b mediated diseases and disorders |
| AR037097A1 (es) | 2001-10-05 | 2004-10-20 | Novartis Ag | Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento |
| US6939224B2 (en) * | 2002-03-12 | 2005-09-06 | Igt | Gaming device having varying risk player selections |
| KR102718287B1 (ko) | 2017-11-14 | 2024-10-16 | 머크 샤프 앤드 돔 엘엘씨 | 인돌아민 2,3-디옥시게나제 (ido) 억제제로서의 신규 치환된 비아릴 화합물 |
| WO2019099294A1 (en) | 2017-11-14 | 2019-05-23 | Merck Sharp & Dohme Corp. | Novel substituted biaryl compounds as indoleamine 2,3-dioxygenase (ido) inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5003106A (en) * | 1983-07-19 | 1991-03-26 | American Cyanamid Company | Antiatherosclerotic ureas and thioureas |
| US5245068A (en) * | 1990-10-30 | 1993-09-14 | Warner-Lambert Company | Oxysulfonyl carbamates |
| ES2067254T3 (es) * | 1990-10-30 | 1995-03-16 | Warner Lambert Co | Oxisulfonilcarbamatos. |
| IL101785A0 (en) * | 1991-05-10 | 1992-12-30 | Fujisawa Pharmaceutical Co | Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
| US5491172A (en) * | 1993-05-14 | 1996-02-13 | Warner-Lambert Company | N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
| IL109431A (en) * | 1993-05-14 | 2001-01-11 | Warner Lambert Co | Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds |
-
1996
- 1996-07-08 EA EA199800176A patent/EA002435B1/ru not_active IP Right Cessation
- 1996-07-08 DK DK96923687T patent/DK0841913T3/da active
- 1996-07-08 PL PL96324908A patent/PL185943B1/pl unknown
- 1996-07-08 HU HU9900668A patent/HUP9900668A3/hu unknown
- 1996-07-08 CA CA002221729A patent/CA2221729A1/en not_active Abandoned
- 1996-07-08 WO PCT/US1996/011366 patent/WO1997005868A1/en not_active Ceased
- 1996-07-08 EE EE9800037A patent/EE9800037A/xx unknown
- 1996-07-08 IL IL12224796A patent/IL122247A0/xx unknown
- 1996-07-08 ES ES96923687T patent/ES2191762T3/es not_active Expired - Lifetime
- 1996-07-08 CN CN96196033A patent/CN1192140A/zh active Pending
- 1996-07-08 AU AU64541/96A patent/AU716255B2/en not_active Ceased
- 1996-07-08 GE GEAP19964165A patent/GEP20012511B/en unknown
- 1996-07-08 US US09/000,296 patent/US6117909A/en not_active Expired - Fee Related
- 1996-07-08 KR KR1019980700795A patent/KR19990036127A/ko not_active Ceased
- 1996-07-08 PT PT96923687T patent/PT841913E/pt unknown
- 1996-07-08 DE DE69626118T patent/DE69626118T2/de not_active Expired - Fee Related
- 1996-07-08 SK SK125-98A patent/SK12598A3/sk unknown
- 1996-07-08 NZ NZ312571A patent/NZ312571A/en unknown
- 1996-07-08 EP EP96923687A patent/EP0841913B1/en not_active Expired - Lifetime
- 1996-07-08 AT AT96923687T patent/ATE232097T1/de not_active IP Right Cessation
- 1996-07-08 JP JP9508427A patent/JPH11510184A/ja active Pending
- 1996-07-08 CZ CZ98261A patent/CZ26198A3/cs unknown
- 1996-07-16 HR HR60/003,031A patent/HRP960341A2/hr not_active Application Discontinuation
- 1996-08-02 ZA ZA9606617A patent/ZA966617B/xx unknown
- 1996-08-07 UA UA97126430A patent/UA46030C2/uk unknown
-
1998
- 1998-01-30 BG BG102222A patent/BG63863B1/bg unknown
- 1998-02-03 NO NO980466A patent/NO980466L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9900668A2 (hu) | 1999-06-28 |
| PL324908A1 (en) | 1998-06-22 |
| CA2221729A1 (en) | 1997-02-20 |
| UA46030C2 (uk) | 2002-05-15 |
| DE69626118T2 (de) | 2003-11-27 |
| CN1192140A (zh) | 1998-09-02 |
| KR19990036127A (ko) | 1999-05-25 |
| NO980466D0 (no) | 1998-02-03 |
| BG63863B1 (bg) | 2003-04-30 |
| ES2191762T3 (es) | 2003-09-16 |
| WO1997005868A1 (en) | 1997-02-20 |
| EA002435B1 (ru) | 2002-04-25 |
| HRP960341A2 (en) | 1998-02-28 |
| NO980466L (no) | 1998-02-03 |
| ATE232097T1 (de) | 2003-02-15 |
| US6117909A (en) | 2000-09-12 |
| EP0841913A1 (en) | 1998-05-20 |
| HUP9900668A3 (en) | 2000-08-28 |
| EE9800037A (et) | 1998-08-17 |
| AU6454196A (en) | 1997-03-05 |
| GEP20012511B (en) | 2001-08-27 |
| EA199800176A1 (ru) | 1998-10-29 |
| PL185943B1 (pl) | 2003-09-30 |
| EP0841913B1 (en) | 2003-02-05 |
| CZ26198A3 (cs) | 1998-07-15 |
| ZA966617B (en) | 1997-02-18 |
| BG102222A (en) | 1998-09-30 |
| SK12598A3 (en) | 1999-02-11 |
| NZ312571A (en) | 2000-07-28 |
| PT841913E (pt) | 2003-06-30 |
| AU716255B2 (en) | 2000-02-24 |
| DE69626118D1 (de) | 2003-03-13 |
| DK0841913T3 (da) | 2003-05-05 |
| JPH11510184A (ja) | 1999-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3030356T3 (en) | N-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents | |
| FI943948A0 (fi) | Heterosykliset hiilihappojohdannaiset | |
| ATE247654T1 (de) | Neue heterozyklische verbindungen | |
| DK0759919T3 (da) | Azolidindioner som antihyperglykæmiske midler | |
| PT958296E (pt) | Compostos heterociclicos processo para a sua preparacao composicoes farmaceuticas contendo-os e sua utilizacao no tratamento da diabetes e doencas relacionadas | |
| ATE169295T1 (de) | 2-phenylbenzo(b>furane und -thiophene, verfahren zu deren herstellung und diese enthaltende pharmazeutische präparate | |
| PT98499A (pt) | Processo para a preparacao de novas sulfonamidas substituidas e de composicoes farmaceuticas que as contem | |
| DZ1694A1 (fr) | "n-(2-Aminoethyl)-benzothialozones". | |
| DK0874812T3 (da) | Hidtil ukendte 2,3,5-trimethyl-4-hydroxyanilidderivater, fremstilling deraf og terapeutisk anvendelse deraf | |
| ATE268752T1 (de) | Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung | |
| IL122247A0 (en) | Use of sulfamic acid derivatives acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels | |
| IS1446B6 (is) | Ný díhýdróbenzófúran- og króman-karboxamíð efni, aðferð við framleiðslu þeirra og notkun þeirra semlyf | |
| ES2111352T3 (es) | Uso de diester fosfato para el tratamiento de enfermedades retinianas. | |
| ES2163396T3 (es) | Aminas biologicamente activas. | |
| DE69512208D1 (de) | Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren | |
| DE69616357D1 (de) | Benzocycloalken-verbindungen mit bindungsaffinität an den melatonin-rezeptor, ihre herstellung und verwendung | |
| MX9709275A (es) | Uso de los derivados del acido sulfamico, carbamatos acil sulfonamidas o sulfonil para la manufactura de un medicamento para disminuir los niveles de lipoproteinas. | |
| BR9809313A (pt) | Compostos, promedicamento, medicamento, processo para a sua preparação e utilização dos mesmos | |
| SE9401965D0 (sv) | New compounds | |
| DE69421705D1 (de) | Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen | |
| MX9606133A (es) | Nuevos derivados de 1,1-bis(heteroazolil)alcano y su uso como agentes neuroprotectores. |